Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511232 · ClinicalTrials.gov registry record · Phase 4
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
A Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06511232: Recruiting Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, sponsored by The Methodist Hospital Research Institute.
NCT06511232 is a Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 84 participants, below the 320-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06511232, a Phase 4 study of Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Primary Outcome
The study will measure patient-reported levels of pain on a daily basis (for a total of two weeks) with a symptom journal, which will ask patients to report on a variety of pain-related outcomes including levels of pain throughout different times of day, levels of nausea throughout different times of the day, and what pain medication(s) they are taking and at what time.
Conditions Studied
Interventions
- DRUG Intraosseous Morphine
Study Locations (1)
Texas
- Houston Methodist Research Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2029-07-31 |
| Phase | Phase 4 |
What NCT06511232 shows while recruiting
NCT06511232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 320-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 1 intervention - of which Intraosseous Morphine is the first listed.
NCT06511232 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06511232 about?
NCT06511232 is a clinical study titled "Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction". The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
What is the current status of trial NCT06511232?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2024-08-19. Estimated completion is 2029-07-31.
What conditions does trial NCT06511232 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Tear, Anterior Cruciate Ligament Rupture.
What interventions are being tested in trial NCT06511232?
The interventions under investigation include: Intraosseous Morphine (DRUG).
Who is sponsoring clinical trial NCT06511232?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06511232 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06511232's enrollment target sits among peer trials
84 12th of 24 higher than 13 of 24 other Anterior Cruciate Ligament Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
RECRUITING · Phase 4
-
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
COMPLETED · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI